The prevalence, awareness, treatment and control of dyslipidemia among adults in China
L Pan, Z Yang, Y Wu, RX Yin, Y Liao, J Wang, B Gao… - Atherosclerosis, 2016 - Elsevier
Objectives To analyze the prevalence, awareness, treatment, control and epidemiological
characteristics of dyslipidemia in Chinese adults. Methods In this cross-sectional study, we …
characteristics of dyslipidemia in Chinese adults. Methods In this cross-sectional study, we …
Prevalence, awareness, treatment, and control of dyslipidemia among adults in Beijing, China
L Cai, L Zhang, A Liu, S Li, P Wang - Journal of atherosclerosis and …, 2012 - jstage.jst.go.jp
Aim: The present study aimed to determine the up-to-date prevalence, awareness,
treatment, and control of dyslipidemia, and their distribution and related influencing factors in …
treatment, and control of dyslipidemia, and their distribution and related influencing factors in …
The prevalence, awareness, treatment, and control of dyslipidemia in northeast China: a population-based cross-sectional survey
FL Zhang, YQ Xing, YH Wu, HY Liu, Y Luo… - Lipids in health and …, 2017 - Springer
Background Dyslipidemia is an important independent modifiable risk factor for
cardiovascular disease. The aim of this study was to explore the current prevalence …
cardiovascular disease. The aim of this study was to explore the current prevalence …
Epidemiology of dyslipidemia in Chinese adults: meta-analysis of prevalence, awareness, treatment, and control
Y Huang, L Gao, X Xie, SC Tan - Population health metrics, 2014 - Springer
Background Numerous epidemiology studies on dyslipidemia have been conducted in
China. However, a nationally representative estimate for dyslipidemia prevalence is lacking …
China. However, a nationally representative estimate for dyslipidemia prevalence is lacking …
Prevalence and associated factors of dyslipidemia in the adult Chinese population
To determine the prevalence, associated factors, awareness and control of dyslipidemia in
Chinese living in Greater Beijing, we measured the serum cholesterol concentration in 3251 …
Chinese living in Greater Beijing, we measured the serum cholesterol concentration in 3251 …
Dyslipidemia prevalence, awareness, treatment, control, and risk factors in Chinese rural population: the Henan rural cohort study
X Liu, S Yu, Z Mao, Y Li, H Zhang, K Yang… - Lipids in health and …, 2018 - Springer
Background The prevalence of dyslipidemia continue to increase in recent decades in
China, however, little is known about the recent prevalence, awareness, treatment, control …
China, however, little is known about the recent prevalence, awareness, treatment, control …
Epidemiologic characteristics of dyslipidemia in people aged 18 years and over in China
WH Zhao, J Zhang, Y You, QQ Man, H Li… - … yu fang yi xue za zhi …, 2005 - europepmc.org
Objective To study the difference in prevalence of dyslipidemia, hypercholesterolemia,
hypertriglyceridemia and low blood high-density lipoprotein cholesterol (HDL-C) between …
hypertriglyceridemia and low blood high-density lipoprotein cholesterol (HDL-C) between …
[PDF][PDF] Blood lipid profile and prevalence of dyslipidemia in Chinese adults
WH Zhao, J Zhang, Y Zhai, Y You, QQ Man… - Biomedical and …, 2007 - besjournal.com
Objective To investigate the plasma lipid levels in a national representative sample of
subjects and to determine the prevalence of dyslipidemia in the Chinese population …
subjects and to determine the prevalence of dyslipidemia in the Chinese population …
Awareness, treatment, control, and determinants of dyslipidemia among adults in China
Effective management of dyslipidemia is important. This study aimed to determine the
awareness, treatment, control, and determinants of dyslipidemia in middle-aged and older …
awareness, treatment, control, and determinants of dyslipidemia in middle-aged and older …
High prevalence of dyslipidemia and associated risk factors among rural Chinese adults
GZ Sun, Z Li, L Guo, Y Zhou, HM Yang… - Lipids in health and …, 2014 - Springer
Background Dyslipidemia is a key independent modifiable risk factor for Cardiovascular
Disease, which is a leading contributor to morbidity and mortality in most developed and …
Disease, which is a leading contributor to morbidity and mortality in most developed and …